doi: 10.3389/fphar.2023.1226778 Received 22 May 2023 Accepted 31 July 2023 Published 09 August 2023 Volume 14 - 2023 Edited by Tomoya Tachi, Nagoya City University, Japan Reviewed by Yu Kondo, Toyota Kosei Hospital, Japan Richard Pratley, AdventHealth, United States Updates Copyright 2023 Feng, Tong, Zhang and Tang
M., Roth, T., Scott, C., Birznieks, G., & Klerman, E
An expiration date appears on FDA-approved medications like Mounjaro or Zepbound
DPP4 is widely expressed in several cell types, particularly in exocrine glands and absorptive epithelia
These trials assess the impact of the medication on cardiovascular events, providing valuable information on the safety and potential cardiovascular benefits of the drug
Oregon, North Carolina